Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma von WITZIG, Thomas E, WIERNIK, Peter H, ERVIN-HAYNES, Annette, ZELDIS, Jerome B, VOSE, Julie M, MOORE, Timothy, REEDER, Craig, COLE, Craig, JUSTICE, Glen, KAPLAN, Henry, VORALIA, Michael, PIETRONIGRO, Dennis, TAKESHITA, Kenichi

Volltext

Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma von Wiernik, Peter H, Lossos, Izidore S, Tuscano, Joseph M, Justice, Glen, Vose, Julie M, Cole, Craig E, Lam, Wendy, McBride, Kyle, Wride, Kenton, Pietronigro, Dennis, Takeshita, Kenichi, Ervin-Haynes, Annette, Zeldis, Jerome B, Habermann, Thomas M

Volltext

Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate Marker von HALL, Daniel E, MOFFAT, Bradford A, ROSS, Brian D, STOJANOVSKA, Jadranka, JOHNSON, Timothy D, ZHUOLIN LI, HAMSTRA, Daniel A, REHEMTULLA, Alnawaz, CHENEVERT, Thomas L, CARTER, Julie, PIETRONIGRO, Dennis

Volltext

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma von Habermann, Thomas M., Lossos, Izidore S., Justice, Glen, Vose, Julie M., Wiernik, Peter H., McBride, Kyle, Wride, Kenton, Ervin‐Haynes, Annette, Takeshita, Kenichi, Pietronigro, Dennis, Zeldis, Jerome B., Tuscano, Joseph M.

Volltext

Stereotactic Injection of DTI-015 into Recurrent Malignant Gliomas: Phase I/II Trial von Hassenbusch, Samuel J., Nardone, Emilio M., Levin, Victor A., Leeds, Norman, Pietronigro, Dennis

Volltext

DTI-015 Produces Cures in T9 Gliosarcoma von Pietronigro, Dennis, Dmovsky, Frank, Cravioto, Humberto, Ransohoff, Joseph

Volltext

Single‐agent lenalidomide is active in patients with relapsed or refractory aggressive non‐Hodgkin lymphoma who received prior stem cell transplantation von Vose, Julie M., Habermann, Thomas M., Czuczman, Myron S., Zinzani, Pier Luigi, Reeder, Craig B., Tuscano, Joseph M., Lossos, Izidore S., Li, Ju, Pietronigro, Dennis, Witzig, Thomas E.

Volltext

Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma von Chen, Christine, Reece, Donna E., Siegel, David, Niesvizky, Ruben, Boccia, Ralph V., Stadtmauer, Edward A., Abonour, Rafat, Richardson, Paul, Matous, Jeffrey, Kumar, Shaji, Bahlis, Nizar J., Alsina, Melissa, Vescio, Robert, Coutre, Steven E., Pietronigro, Dennis, Knight, Robert D., Zeldis, Jerome B., Rajkumar, Vincent

Volltext

The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non‐Hodgkin lymphoma of distinct histological origin von Czuczman, Myron S., Vose, Julie M., Witzig, Thomas E., Zinzani, Pier L., Buckstein, Rena, Polikoff, Jonathan, Li, Ju, Pietronigro, Dennis, Ervin‐Haynes, Annetti, Reeder, Craig B.

Volltext

Phase II Multicenter Study of the Safety and Efficacy of Single-Agent Lenalidomide in Subjects with Relapsed/Refractory Mantle Cell Lymphoma: Long-Term Follow-up Analysis of the NH... von Zinzani, Pier Luigi, Vose, Julie M, Czuczman, Myron S., Reeder, Craig, Haioun, Corinne, Polikoff, Jonathan, Tilly, Herve, Pietronigro, Dennis, Ervin-Haynes, Annette, Li, Ju, Witzig, Thomas E.

Volltext

Single-Agent Lenalidomide for Patients with Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma Who Had Received Prior Stem Cell Transplant von Vose, Julie M., Habermann, Thomas, Czuczman, Myron S, Zinzani, Pier Luigi, Reeder, Craig B., Tuscano, Joseph, Lossos, Izidore S, Pietronigro, Dennis, Ervin-Haynes, Annette, Witzig, Thomas

Volltext

Durable Responses After Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory (R/R) Aggressive Non-Hodgkin's Lymphoma (a-NHL): Results From An International Phase 2... von Witzig, Thomas E, Vose, Julie M., Zinzani, Pier Luigi, Reeder, Craig B., Buckstein, Rena, Polikoff, Jonathan, Guo, Pingshan, Pietronigro, Dennis, Ervin-Haynes, Annette, Czuczman, Myron S

Volltext

The Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Mantle Cell Lymphoma Previously Treated with Bortezomib: Pooled Data from Two Phase II Studies (NHL-002 an... von Reeder, Craig B., Witzig, T.E., Vose, Julie M., Zinzani, Pier Luigi, Buckstein, Rena, Haioun, Corinne, Bouabdallah, Reda, Polikoff, Jonathan, Guo, Pingshan, Ervin-Haynes, Annette, Pietronigro, Dennis, Zeldis, Jerome B., Czuczman, Myron S.

Volltext

Confirmation of the Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory Diffuse Large-B-Cell Lymphoma: Results of An International Study (N... von Czuczman, Myron S., Vose, Julie M., Zinzani, Pier Luigi, Reeder, Craig B., Buckstein, Rena, Haioun, Corinne, Bouabdallah, Reda, Polikoff, Jonathan, Guo, Pingshan, Ervin-Haynes, Annette, Pietronigro, Dennis, Zeldis, Jerome B., Witzig, Thomas E.

Volltext

Confirmation of the Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: Results of An International Study (NHL-003) von Zinzani, Pier Luigi, Witzig, Thomas E., Vose, Julie M., Reeder, Craig B., Buckstein, Rena, Haioun, Corinne, Bouabdallah, Reda, Polikoff, Jonathan, Guo, Pingshan, Ervin-Hayes, Annette, Pietronigro, Dennis, Zeldis, Jerome B., Czuczman, Myron S.

Volltext

Lenalidomide Oral Monotherapy Produces a 53% Response Rate in Patients with Relapsed/Refractory Mantle-Cell Non-Hodgkin's Lymphoma von Tuscano, Joseph M., Lossos, Izidore S., Justice, Glen, Vose, Julie M., Takeshita, Kenichi, Ervin-Haynes, Annette, Pietronigro, Dennis, Zeldis, Jerome B., Habermann, Thomas M.

Volltext

High Response Rate to Lenalidomide in Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma with Prior Stem Cell Transplant von Vose, Julie M., Tuscano, Joseph M., Justice, Glen, Lossos, Izidore S., Ervin-Haynes, Annette, Takeshita, Kenichi, Pietronigro, Dennis, Zeldis, Jerome B., Habermann, Thomas M.

Volltext

SYSTEMS METHODS AND DATA STRUCTURES FOR EFFICIENT PROCESSING AND PRESENTATION OF PATIENT MEDICAL DATA von HUANG, Jianping, PIETRONIGRO, Dennis

Volltext bestellen

Results from a Phase II Study of Lenalidomide Oral Monotherapy in Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma von Witzig, Thomas E., Vose, Julie M., Moore, Timothy D., Reeder, Craig B., Cole, Craig E., Justice, Glen, Kaplan, Henry P., Voralia, Michael, Pietronigro, Dennis, Takeshita, Kenichi, Ervin-Haynes, Annette, Zeldis, Jerome B., Wiernik, Peter H.

Volltext

Lenalidomide Response in Relapsed/Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma von Lossos, Izidore S., Wiernik, Peter H., Justice, Glen, Tuscano, Joseph M., Cole, Craig E., Vose, Julie M., Pietronigro, Dennis, Takeshita, Kenichi, Ervin-Haynes, Annette, Zeldis, Jerome B., Habermann, Thomas M.

Volltext